Owlet expands medically-certified baby monitor to South Africa

Owlet, Inc. (NYSE:OWLT), a $127 million market cap company, is aggressively expanding its global footprint, launching its medically-certified Dream Sock infant monitor in South Africa and securing Australian TGA certification. While the company reported strong Q2 2025 revenue of $26.1 million, significantly exceeding forecasts, it posted a substantial EPS miss of -$2.53 and remains unprofitable despite 37% last twelve months revenue growth. This strategic international push for its core product underscores Owlet's focus on market penetration amidst ongoing profitability challenges.

Analysis

Owlet, Inc. (OWLT) is demonstrating aggressive execution on its global expansion strategy, but this top-line growth is currently overshadowed by significant profitability challenges. The company recently launched its medically-certified Dream Sock monitor in South Africa and secured TGA certification in Australia, milestones that underscore its go-to-market progress and establish regulatory moats in new regions. This expansion is supported by strong revenue performance, including a 37% increase over the last twelve months and a Q2 2025 revenue of $26.1 million, which substantially beat the $20.07 million forecast. However, the company's financial health remains a key concern. Despite the revenue beat, Owlet posted a substantial Q2 earnings miss with an EPS of -$2.53 against a projected $0.10, confirming it is not yet profitable. The stock's nearly 70% year-to-date surge indicates that the market has been rewarding the growth narrative, but the deep EPS miss highlights the cash burn and the long path to bottom-line stability for this $127 million market cap company.

Key Decisions for Investors

• Investors should weigh the company's impressive revenue growth and successful international expansion against its significant unprofitability and substantial cash burn, as highlighted by the recent deep EPS miss.
• Monitor future earnings reports closely for any improvement in profit margins and track sales velocity in new markets like South Africa and Australia to validate the execution of the growth strategy.
• Given the stock's high volatility and small-cap status, investors should treat OWLT as a high-risk, speculative growth investment and ensure any position size aligns with their risk tolerance.